Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (651-660 of 850) with videos related to

Pageof 85
Sort By:
International Urology and Nephrology|November 19, 2021
Survival after radical prostatectomy vs. radiation therapy in ductal carcinoma of the prostateFrancesco Chierigo, Marco Borghesi, Christoph Würnschimmel, et al.
Human Pathology|November 29, 2015
Aquaporin 5 expression is frequent in prostate cancer and shows a dichotomous correlation with tumor phenotype and PSA recurrenceAlexandra Pust, Dominik Kylies, Claudia Hube-Magg, et al.
BJU International|October 13, 2006
Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patientsFelix K-H Chun, Alberto Briganti, Elie Antebi, et al.
European Urology|April 2, 2014
Pretreatment tables predicting pathologic stage of locally advanced prostate cancerSteven Joniau, Martin Spahn, Alberto Briganti, et al.
European Urology|April 21, 2024
Current Standards for Training in Robot-assisted Surgery and Endourology: A Systematic ReviewGiuseppe Basile, Andrea Gallioli, Pietro Diana, et al.
Marine Drugs|May 15, 2020
Inspired by Sea Urchins: Warburg Effect Mediated Selectivity of Novel Synthetic Non-Glycoside 1,4-Naphthoquinone-6S-Glucose Conjugates in Prostate CancerSergey A Dyshlovoy, Dmitry N Pelageev, Jessica Hauschild, et al.
BJU International|September 16, 2009
Differences in histopathological and biochemical outcomes in patients with low Gleason score prostate cancerHendrik Isbarn, Pierre I Karakiewicz, Sascha A Ahyai, et al.
European Urology|October 4, 2025
Best Systemic Therapy With or Without Radical Prostatectomy in the Management of Men With Oligometastatic Prostate Cancer: The RAMPP Randomised Controlled TrialMarkus Graefen, Fabian Falkenbach, Tobias Maurer, et al.
European Urology|June 19, 2022
Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via Prostate-specific Membrane Antigen-radioguided SurgerySophie Knipper, Mehrdad Mehdi Irai, Ricarda Simon, et al.
International Urology and Nephrology|May 4, 2022
Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicityFrancesco Chierigo, Marco Borghesi, Christoph Würnschimmel, et al.
Pageof 85

Showing results (651-660 of 850) with videos related to

Sort By:
Pageof 85
International Urology and Nephrology|November 19, 2021
Survival after radical prostatectomy vs. radiation therapy in ductal carcinoma of the prostateFrancesco Chierigo, Marco Borghesi, Christoph Würnschimmel, et al.
Human Pathology|November 29, 2015
Aquaporin 5 expression is frequent in prostate cancer and shows a dichotomous correlation with tumor phenotype and PSA recurrenceAlexandra Pust, Dominik Kylies, Claudia Hube-Magg, et al.
BJU International|October 13, 2006
Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patientsFelix K-H Chun, Alberto Briganti, Elie Antebi, et al.
European Urology|April 2, 2014
Pretreatment tables predicting pathologic stage of locally advanced prostate cancerSteven Joniau, Martin Spahn, Alberto Briganti, et al.
European Urology|April 21, 2024
Current Standards for Training in Robot-assisted Surgery and Endourology: A Systematic ReviewGiuseppe Basile, Andrea Gallioli, Pietro Diana, et al.
Marine Drugs|May 15, 2020
Inspired by Sea Urchins: Warburg Effect Mediated Selectivity of Novel Synthetic Non-Glycoside 1,4-Naphthoquinone-6S-Glucose Conjugates in Prostate CancerSergey A Dyshlovoy, Dmitry N Pelageev, Jessica Hauschild, et al.
BJU International|September 16, 2009
Differences in histopathological and biochemical outcomes in patients with low Gleason score prostate cancerHendrik Isbarn, Pierre I Karakiewicz, Sascha A Ahyai, et al.
European Urology|October 4, 2025
Best Systemic Therapy With or Without Radical Prostatectomy in the Management of Men With Oligometastatic Prostate Cancer: The RAMPP Randomised Controlled TrialMarkus Graefen, Fabian Falkenbach, Tobias Maurer, et al.
European Urology|June 19, 2022
Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via Prostate-specific Membrane Antigen-radioguided SurgerySophie Knipper, Mehrdad Mehdi Irai, Ricarda Simon, et al.
International Urology and Nephrology|May 4, 2022
Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicityFrancesco Chierigo, Marco Borghesi, Christoph Würnschimmel, et al.
Pageof 85